BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7933810)

  • 1. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury.
    Wheeler DC; Chana RS; Topley N; Petersen MM; Davies M; Williams JD
    Kidney Int; 1994 Jun; 45(6):1628-36. PubMed ID: 7933810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms of lipid injury in the glomerulus.
    Schlondorff D
    Am J Kidney Dis; 1993 Jul; 22(1):72-82. PubMed ID: 8322798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative modification of low-density lipoproteins by mesangial cells.
    Keane WF; O'Donnell MP; Kasiske BL; Kim Y
    J Am Soc Nephrol; 1993 Aug; 4(2):187-94. PubMed ID: 8400082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro.
    Coritsidis G; Rifici V; Gupta S; Rie J; Shan ZH; Neugarten J; Schlondorff D
    Kidney Int; 1991 May; 39(5):858-66. PubMed ID: 2067202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of low density lipoprotein with rat mesangial cells.
    Wasserman J; Santiago A; Rifici V; Holthofer H; Scharschmidt L; Epstein M; Schlondorff D
    Kidney Int; 1989 May; 35(5):1168-74. PubMed ID: 2770101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native and oxidized low density lipoproteins modulate mesangial cell apoptosis.
    Sharma P; Reddy K; Franki N; Sanwal V; Sankaran R; Ahuja TS; Gibbons N; Mattana J; Singhal PC
    Kidney Int; 1996 Nov; 50(5):1604-11. PubMed ID: 8914027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lipoproteins on cultured human mesangial cells.
    Nishida Y; Yorioka N; Oda H; Yamakido M
    Am J Kidney Dis; 1997 Jun; 29(6):919-30. PubMed ID: 9186079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-density lipoproteins on mesangial cell growth and viability in vitro.
    Wheeler DC; Persaud JW; Fernando R; Sweny P; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1990; 5(3):185-91. PubMed ID: 2113645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
    Krämer-Guth A; Greiber S; Pavenstädt H; Quaschning T; Winkler K; Schollmeyer P; Wanner C
    Kidney Int; 1996 May; 49(5):1250-61. PubMed ID: 8731088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation.
    Kamanna VS; Pai R; Roh DD; Kirschenbaum MA
    Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein.
    Neugarten J; Ghossein C; Silbiger S
    J Lab Clin Med; 1995 Oct; 126(4):385-91. PubMed ID: 7561448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipoproteins on mesangial cell proliferation.
    Nishida Y; Oda H; Yorioka N
    Kidney Int Suppl; 1999 Jul; 71():S51-3. PubMed ID: 10412737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells.
    Lee HS; Koh HI
    Lab Invest; 1994 Aug; 71(2):200-8. PubMed ID: 7521444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.
    Massy ZA; Kim Y; Guijarro C; Kasiske BL; Keane WF; O'Donnell MP
    Biochem Biophys Res Commun; 2000 Jan; 267(2):536-40. PubMed ID: 10631097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells.
    Lee HS; Kim BC; Kim YS; Choi KH; Chung HK
    Kidney Int; 1996 Nov; 50(5):1582-90. PubMed ID: 8914025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins.
    Roh DD; Kamanna VS; Kirschenbaum MA
    Am J Nephrol; 1998; 18(4):344-50. PubMed ID: 9653842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9HODE stimulates cell proliferation and extracellular matrix synthesis in human mesangial cells via PPARgamma.
    Negishi M; Shimizu H; Okada S; Kuwabara A; Okajima F; Mori M
    Exp Biol Med (Maywood); 2004 Nov; 229(10):1053-60. PubMed ID: 15522842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells.
    Kim SB; Kang SA; Cho YJ; Park SK; Cheong HI; Lee JD; Hong CD; Park JS
    Nephron; 1994; 67(3):327-33. PubMed ID: 7936024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells.
    Pai R; Kirschenbaum MA; Kamanna VS
    Kidney Int; 1995 Oct; 48(4):1254-62. PubMed ID: 8569087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.